The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Roche
UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602).
 
Craig Gedye
Honoraria - Novotech
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Novotech; Pfizer (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Merck Sharp & Dohme
 
David William Pook
Honoraria - Astellas Pharma; Ipsen; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme (Inst); Pfizer (Inst)
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Pfizer
 
Laurence Eliot Miles Krieger
Honoraria - Astellas Pharma; Ferring; Ipsen; Janssen-Cilag; Janssen-Cilag; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ferring; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Abbvie; Janssen-Cilag; Merck Sharp & Dohme; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); Roche (Inst)
Expert Testimony - Astellas Pharma; Ipsen; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer
 
Carole A. Harris
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jeffrey C. Goh
Stock and Other Ownership Interests - Immutep
Consulting or Advisory Role - AstraZeneca; Tesaro
Speakers' Bureau - Ipsen; Janssen; Mundipharma; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
Ganessan Kichenadasse
No Relationships to Disclose
 
Howard Gurney
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Speakers' Bureau - AstraZeneca; AstraZeneca
Travel, Accommodations, Expenses - Astellas Pharma
 
Craig Underhill
No Relationships to Disclose
 
Francis Parnis
Consulting or Advisory Role - Astellas Medivation; Ipsen; Janssen Oncology; Pfizer
Travel, Accommodations, Expenses - Amgen; Astellas Medivation; Ipsen
 
Anthony M. Joshua
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Thomas Ferguson
No Relationships to Disclose
 
Felicia Roncolato
No Relationships to Disclose
 
Michelle L. Harrison
Stock and Other Ownership Interests - CSL Limited (I)
 
Michelle Frances Morris
Travel, Accommodations, Expenses - Amgen
 
Stephen Begbie
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Pfizer; Roche
Research Funding - Astellas Medivation; Boston Biomedical; Janssen Oncology; Merck; Merck Serono; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Teva
 
Elizabeth J. Hovey
No Relationships to Disclose
 
Mathew George
No Relationships to Disclose
 
Prashanth Prithviraj
No Relationships to Disclose
 
Elizabeth Chien Hern Liow
Travel, Accommodations, Expenses - Pfizer
 
Ian D. Davis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.